156 related articles for article (PubMed ID: 8372684)
21. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
[TBL] [Abstract][Full Text] [Related]
22. Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown.
Chilosi M; Iannucci A; Fiore-Donati L; Tridente G; Pampanin M; Pizzolo G; Ritter M; Bofill M; Janossy G
J Neuroimmunol; 1986 May; 11(3):191-204. PubMed ID: 3514666
[TBL] [Abstract][Full Text] [Related]
23. Letter: B lymphocytes in the thymus of patients with myasthenia gravis.
Staber FG; Fink U; Sack W
N Engl J Med; 1975 May; 292(19):1032-3. PubMed ID: 1078872
[No Abstract] [Full Text] [Related]
24. Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis.
Berrih-Aknin S; Ragheb S; Le Panse R; Lisak RP
Autoimmun Rev; 2013 Jul; 12(9):885-93. PubMed ID: 23537509
[TBL] [Abstract][Full Text] [Related]
25. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
Meinl E; Klinkert WE; Wekerle H
Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical and enzyme histochemical contributions to the problem concerning the role of the thymus in the pathogenesis of myasthenia gravis.
Palestro G; Tridente G; Botto Micca F; Novero D; Valente G; Godio L
Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 44(2):173-86. PubMed ID: 6139909
[TBL] [Abstract][Full Text] [Related]
27. Thymic B-cell activation in myasthenia gravis.
Levinson AI; Zweiman B; Lisak RP; Dziarski A; Moskovitz AR
Neurology; 1984 Apr; 34(4):462-8. PubMed ID: 6608064
[TBL] [Abstract][Full Text] [Related]
28. Thymic lymphocytes in myasthenia gravis.
Birnbaum G; Tsairis P
Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
[TBL] [Abstract][Full Text] [Related]
29. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
Hohlfeld R; Wekerle H
J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
[TBL] [Abstract][Full Text] [Related]
30. [Thymus gland pathology in myasthenia gravis: cause or consequence?].
Zaĭrat'iants OV; Vetshev PS; Khavinson VKh; Ippolitov IKh; Shakhova OV
Sov Med; 1990; (8):18-25. PubMed ID: 2274814
[TBL] [Abstract][Full Text] [Related]
31. Morphological Changes in the Thymus, Composition of Its Cells, and Subpopulations of Peripheral Blood Lymphocytes during Experimental Acute Ulcerative Colitis.
Makarova OV; Postovalova EA
Bull Exp Biol Med; 2017 Sep; 163(5):681-686. PubMed ID: 28944427
[TBL] [Abstract][Full Text] [Related]
32. B- and T-cell activation in the thymus of patients with myasthenia gravis.
Cohen-Kaminsky S; Leprince C; Galanaud P; Richards Y; Berrih-Aknin S
Thymus; 1989; 14(1-3):187-93. PubMed ID: 2623739
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory bowel diseases and thymus disorder: reactivity of thymocytes with monoclonal antibodies.
Mizuno Y; Muraoka M; Shimabukuro K; Toda K; Miyagawa K; Yoshimatsu H; Tsuchiya M
Bull Tokyo Dent Coll; 1990 May; 31(2):137-41. PubMed ID: 2131166
[TBL] [Abstract][Full Text] [Related]
34. Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis.
Zhang J; Cohen-Kaminsky S; Berrih-Aknin S
Hum Antibodies Hybridomas; 1995; 6(4):153-60. PubMed ID: 8688498
[TBL] [Abstract][Full Text] [Related]
35. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the thymus in Lrp4 myasthenia gravis: Four cases.
Koneczny I; Rennspiess D; Marcuse F; Dankerlui N; Abdul Hamid M; Mané-Damas M; Maessen J; Van Schil P; Saxena A; Zisimopoulou P; Lazaridis K; Woodhall M; Karagiorgou K; Tzartos J; Tzartos S; De Baets MH; Molenaar PC; Marx A; Zur Hausen A; Losen M; Martinez-Martinez P
Autoimmun Rev; 2019 Jan; 18(1):50-55. PubMed ID: 30414949
[TBL] [Abstract][Full Text] [Related]
37. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
38. Subsets of lymphoid cells in blood and thymus in myasthenia gravis. Monoclonal antibody analysis.
Fujii N; Itoyama Y; Tabira T; Kuroiwa Y
J Neuroimmunol; 1983 Jun; 4(3):151-9. PubMed ID: 6343429
[TBL] [Abstract][Full Text] [Related]
39. The thymus and myasthenia gravis.
Ragheb S; Lisak RP
Chest Surg Clin N Am; 2001 May; 11(2):311-27, x. PubMed ID: 11413758
[TBL] [Abstract][Full Text] [Related]
40. [Distribution of B-lymphocyte subgroup CD20 and its clinical significance in patients with myasthenia gravis].
Zhang Q; Hu Y; Zhang L; Li Y; Yin H; Li J
Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):239-41. PubMed ID: 11825378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
